246 related articles for article (PubMed ID: 8576796)
1. Effects of angiotensin converting enzyme inhibitors on the progression of diabetic nephropathy.
Ruilope LM
J Hypertens Suppl; 1995 Aug; 13(2):S91-3. PubMed ID: 8576796
[TBL] [Abstract][Full Text] [Related]
2. [The effect of angiotensin-converting enzyme inhibitors on the progression of chronic renal failure].
Bernadet-Monrozies P; Rostaing L; Kamar N; Durand D
Presse Med; 2002 Nov; 31(36):1714-20. PubMed ID: 12467154
[TBL] [Abstract][Full Text] [Related]
3. Renal protection and antihypertensive drugs: current status.
Salvetti A; Mattei P; Sudano I
Drugs; 1999 May; 57(5):665-93. PubMed ID: 10353294
[TBL] [Abstract][Full Text] [Related]
4. [Risk and prevention of diabetic nephropathy].
Ravera M; Re M; Deferrari G
G Ital Nefrol; 2007; 24 Suppl 38():13-9. PubMed ID: 17922442
[TBL] [Abstract][Full Text] [Related]
5. ACE inhibitors or ARBs for diabetic nephropathy: the unrelenting debate.
Kota SK; Meher LK; Jammula S; Kota SK; Modi KD
Diabetes Metab Syndr; 2012; 6(4):215-7. PubMed ID: 23199543
[TBL] [Abstract][Full Text] [Related]
6. Retarding the progression of diabetic nephropathy in type 2 diabetes mellitus: focus on hypertension and proteinuria.
Lee GS
Ann Acad Med Singap; 2005 Jan; 34(1):24-30. PubMed ID: 15726216
[TBL] [Abstract][Full Text] [Related]
7. Pharmacologic management of diabetic nephropathy.
Vivian EM; Rubinstein GB
Clin Ther; 2002 Nov; 24(11):1741-56; discussion 1719. PubMed ID: 12501871
[TBL] [Abstract][Full Text] [Related]
8. Antihypertensive drugs and diabetic nephropathy.
Mehler PS; Schrier RW
Curr Hypertens Rep; 1999; 1(2):170-7. PubMed ID: 10981062
[TBL] [Abstract][Full Text] [Related]
9. The effect of beta-blockade and angiotensin converting enzyme inhibition on kidney function in diabetic nephropathy.
Hommel E
J Hypertens Suppl; 1989 Sep; 7(7):S49-51. PubMed ID: 2575661
[TBL] [Abstract][Full Text] [Related]
10. Therapeutic controversies in hypertension management: angiotensin converting enzyme (ACE) inhibitors or angiotensin receptor blockers for diabetic nephropathy? A case for ACE inhibitors.
Crook ED; Preddie DC
Ethn Dis; 2002; 12(4):S3-49-52. PubMed ID: 12477155
[TBL] [Abstract][Full Text] [Related]
11. [Renoprotective effects of ACE inhibitors and AT1 antagonists on diabetic nephropathy beyond blood pressure control].
Shionoiri H; Yasuda G; Takizawa T; Shionoiri F
Nihon Rinsho; 2005 Jun; 63 Suppl 6():394-9. PubMed ID: 15999741
[No Abstract] [Full Text] [Related]
12. Management of Hypertension in Diabetic Nephropathy: How Low Should We Go?
Sternlicht H; Bakris GL
Blood Purif; 2016; 41(1-3):139-43. PubMed ID: 26766168
[TBL] [Abstract][Full Text] [Related]
13. Decline of renal function is associated with proteinuria and systolic blood pressure in the morning in diabetic nephropathy.
Suzuki H; Kanno Y; Nakamoto H; Okada H; Sugahara S
Clin Exp Hypertens; 2005; 27(2-3):129-38. PubMed ID: 15835375
[TBL] [Abstract][Full Text] [Related]
14. Natural history of early diabetic nephropathy: what are the effects of therapeutic intervention? Melbourne Diabetic Nephropathy Study Group.
Jerums G; Allen TJ; Gilbert RE; Hammond J; Cooper ME; Campbell DJ; Raffaele J
J Diabetes Complications; 1995; 9(4):308-14. PubMed ID: 8573754
[TBL] [Abstract][Full Text] [Related]
15. [Effect of blood glucose and blood pressure control on progression of diabetic nephropathy].
Schwarz C; Oberbauer R
Wien Klin Wochenschr; 2000 Nov; 112(21):907-11. PubMed ID: 11144004
[TBL] [Abstract][Full Text] [Related]
16. Recent advances in pharmacological management of hypertension in diabetic patients with nephropathy. Effects of antihypertensive drugs on kidney function and insulin sensitivity.
Baba T; Ishizaki T
Drugs; 1992 Apr; 43(4):464-89. PubMed ID: 1377114
[TBL] [Abstract][Full Text] [Related]
17. Evolving strategies for renoprotection: diabetic nephropathy.
Parving HH; Hovind P; Rossing K; Andersen S
Curr Opin Nephrol Hypertens; 2001 Jul; 10(4):515-22. PubMed ID: 11458033
[TBL] [Abstract][Full Text] [Related]
18. [The role of ramipril in the therapy of diabetic nephropathy].
Dézsi CA
Orv Hetil; 2014 Feb; 155(7):263-9. PubMed ID: 24509355
[TBL] [Abstract][Full Text] [Related]
19. The role of angiotensin II antagonism in type 2 diabetes mellitus: a review of renoprotection studies.
Zanella MT; Ribeiro AB
Clin Ther; 2002 Jul; 24(7):1019-34. PubMed ID: 12182249
[TBL] [Abstract][Full Text] [Related]
20. Predictors of the progression of diabetic nephropathy and the beneficial effect of angiotensin-converting enzyme inhibitors in NIDDM patients.
Yokoyama H; Tomonaga O; Hirayama M; Ishii A; Takeda M; Babazono T; Ujihara U; Takahashi C; Omori Y
Diabetologia; 1997 Apr; 40(4):405-11. PubMed ID: 9112017
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]